Pharmacokinetic Analysis of Malignant Pleural Mesothelioma-Initial Results of Tumor Microcirculation and its Correlation to Microvessel Density (CD-34)

Academic Radiology

Volumn 15, Issue 5, 2008, Pages 563-570

  Giesel, Frederik L ^a,e   Choyke, Peter L ^b   Mehndiratta, Amit ^a,c   Zechmann, Christian M ^a   von Tengg Kobligk, Henrik ^a   Kayser, Klaus ^d   Bischoff, Helge ^a   Hintze, Christian ^a   Delorme, Stefan ^a   Weber, M A ^a   Essig, Marco ^a   Kauczor, Hans Ulrich ^a   Knopp, Michael V ^e  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c INDIAN INSTITUTE OF TECHNOLOGY   (India)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

Angiogenesis; CD 34; dynamic contrast enhanced MRI; malignant mesothelioma; microvascular density; pharmacokinetic analysis

Indexed keywords

CD34 ANTIBODY;

ADULT; AGED; ANTIANGIOGENIC THERAPY; AORTA; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; MALE; MICROCIRCULATION; MICROVASCULATURE; MICROVESSEL DENSITY; MUSCLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACOKINETICS; PHYSIOLOGY; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; SPLEEN; STATISTICAL SIGNIFICANCE; ULTRASTRUCTURE;

AGED; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MESOTHELIOMA; MICROCIRCULATION; MIDDLE AGED; PLEURAL NEOPLASMS;

EID: 41949126180     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2007.12.014     Document Type: Article

References (28)

1. Kayser K., Becker C., Seeberg N., et al. Quantitation of asbestos and asbestos-like fibers in human lung tissue by hot and wet ashing, and the significance of their presence for survival of lung carcinoma and mesothelioma patients. Lung Cancer 24 (1999) 89-98
2. Kayser K., Bohm G., Blum S., et al. Glyco- and immunohistochemical refinement of the differential diagnosis between mesothelioma and metastatic carcinoma and survival analysis of patients. J Pathol 193 (2001) 175-180
3. Sugarbaker D.J., Flores R.M., Jaklitsch M.T., et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 117 (1999) 54-63
4. Choyke P.L., Dwyer A.J., and Knopp M.V. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 17 (2003) 509-520
5. Knopp M.V., Weiss E., Sinn H.P., et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 10 (1999) 260-266
6. Nosas-Garcia S., Moehler T., Wasser K., et al. Dynamic contrast-enhanced MRI for assessing the disease activity of multiple myeloma: a comparative study with histology and clinical markers. J Magn Reson Imaging 22 (2005) 154-162
7. Hylton N. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol 24 (2006) 3293-3298
8. Hawighorst H., Knopp M.V., Debus J., et al. Pharmacokinetic MRI for assessment of malignant glioma response to stereotactic radiotherapy: initial results. J Magn Reson Imaging 8 (1998) 783-788
9. Knopp M.V., Tengg-Kobligk H., and Choyke P.L. Functional magnetic resonance imaging in oncology for diagnosis and therapy monitoring. Mol Cancer Ther 2 (2003) 419-426
10. Padhani A.R., Gapinski C.J., Macvicar D.A., et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 55 (2000) 99-109
11. Mayr N.A., Hawighorst H., Yuh W.T., et al. MR microcirculation assessment in cervical cancer: correlations with histomorphological tumor markers and clinical outcome. J Magn Reson Imaging 10 (1999) 267-276
12. Butchart E.G., Ashcroft T., Barnsley W.C., et al. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 31 (1976) 15-24
13. Butchart E.G. Surgery of mesothelioma of the pleura. In: Roth J.A., Ruckdeschel J.C., and Weinseinberger T.H. (Eds). Thoracic oncology (1989), WB Saunders Co, Philadelphia, PA 566-583
14. Hoffmann U., Brix G., Knopp M.V., et al. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med 33 (1995) 506-514
15. Brix G., Semmler W., Port R., et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 15 (1991) 621-628
16. Kayser K., Trott J., Bohm G., et al. Localized fibrous tumors (LFTs) of the pleura: clinical data, asbestos burden, and syntactic structure analysis applied to newly defined angiogenic/growth-regulatory effectors. Pathol Res Pract 201 (2005) 791-801
17. Kayser K., and Gabius H.J. The application of thermodynamic principles to histochemical and morphometric tissue research: principles and practical outline with focus on the glycosciences. Cell Tissue Res 296 (1999) 443-455
18. Zou K.H., Tuncali K., and Silverman S.G. Correlation and simple linear regression. Radiology 227 (2003) 617-622
19. Szoke T., Kayser K., Baumhakel J.D., et al. Prognostic significance of microvascularization in cases of operated lung cancer. Eur J Cardiothorac Surg 27 (2005) 1106-1111
20. Kayser G., Baumhakel J.D., Szoke T., et al. Vascular diffusion density and survival of patients with primary lung carcinomas. Virchows Arch 442 (2003) 462-467
21. Galbraith S.M., Rustin G.J., Lodge M.A., et al. Effects of 5,6-dimethylxanthenone-4-acetic acid on human tumor microcirculation assessed by dynamic contrast-enhanced magnetic resonance imaging. J Clin Oncol 20 (2002) 3826-3840
22. Sorensen A.G. Magnetic resonance as a cancer imaging biomarker. J Clin Oncol 24 (2006) 3274-3281
23. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 285 (1971) 1182-1186
24. Martincich L., Montemurro F., De Rosa G., et al. Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 83 (2004) 67-76
25. Weidner N., Semple J.P., Welch W.R., et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324 (1991) 1-8
26. Mattern J., Koomagi R., and Volm M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br J Cancer 73 (1996) 931-934
27. Kumar-Singh S., Vermeulen P.B., Weyler J., et al. Evaluation of tumour angiogenesis as a prognostic marker in malignant mesothelioma. J Pathol 182 (1997) 211-216
28. Ohta Y., Shridhar V., Bright R.K., et al. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. Br J Cancer 81 (1999) 54-61